tradingkey.logo

OptimizeRx Corp

OPRX

12.860USD

+0.360+2.88%
收盘 08/04, 16:00美东报价延迟15分钟
237.82M总市值
亏损市盈率 TTM

OptimizeRx Corp

12.860

+0.360+2.88%
关于 OptimizeRx Corp 公司
OptimizeRx Corporation 是一家数字健康技术公司,致力于在患者护理过程中的关键时刻,促进生命科学组织、医疗保健提供者和患者之间的以护理为中心的互动。该公司通过其人工智能 (AI) 生成的动态受众和激活平台 (DAAP) 提供各种技术支持的营销解决方案,使客户能够在其数字护理点网络上开展传统营销活动,以及动态营销活动,这些活动可以实时优化受众,从而提高治疗信息对医疗保健专业人员和患者的价值,以响应临床护理事件。其主要解决方案包括受众开发、受众激活和媒体执行以及财务消息传递。其财务消息传递解决方案使处方者可以直接在其电子健康记录 (EHR) 系统和/或电子处方 (ERx) 平台中查看品牌共付额优惠。
公司简介
公司代码OPRX
公司名称OptimizeRx Corp
上市日期May 18, 2005
CEOMr. Stephen L. (Steve) Silvestro
员工数量106
证券类型Ordinary Share
年结日May 18
公司地址260 Charles Street
城市WALTHAM
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编02453
电话12486516558
网址https://www.optimizerx.com/
公司代码OPRX
上市日期May 18, 2005
CEOMr. Stephen L. (Steve) Silvestro
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. James (Jim) Lang
Mr. James (Jim) Lang
Independent Director
Independent Director
386.03K
+2.62%
Mr. Stephen L. (Steve) Silvestro
Mr. Stephen L. (Steve) Silvestro
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
119.10K
+65.06%
Ms. Theresa Greco
Ms. Theresa Greco
Chief Commercial Officer
Chief Commercial Officer
62.93K
+17.74%
Mr. Doug Besch
Mr. Doug Besch
Chief Product Officer and Chief Technology Officer
Chief Product Officer and Chief Technology Officer
51.60K
-2.62%
Mr. Edward (Ed) Stelmakh
Mr. Edward (Ed) Stelmakh
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
46.65K
-47.02%
Mr. Gregory D. (Greg) Wasson
Mr. Gregory D. (Greg) Wasson
Independent Director
Independent Director
43.90K
+29.00%
Mr. Patrick D. (Pat) Spangler
Mr. Patrick D. (Pat) Spangler
Independent Director
Independent Director
42.05K
+30.66%
Ms. Catherine M. Klema
Ms. Catherine M. Klema
Independent Director
Independent Director
14.98K
+193.15%
Ms. Marion K. Odence-Ford
Ms. Marion K. Odence-Ford
General Legal Officer and Chief Human Resources Officer
General Legal Officer and Chief Human Resources Officer
--
--
Mr. Andy Dsilva
Mr. Andy Dsilva
Investor Relations
Investor Relations
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. James (Jim) Lang
Mr. James (Jim) Lang
Independent Director
Independent Director
386.03K
+2.62%
Mr. Stephen L. (Steve) Silvestro
Mr. Stephen L. (Steve) Silvestro
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
119.10K
+65.06%
Ms. Theresa Greco
Ms. Theresa Greco
Chief Commercial Officer
Chief Commercial Officer
62.93K
+17.74%
Mr. Doug Besch
Mr. Doug Besch
Chief Product Officer and Chief Technology Officer
Chief Product Officer and Chief Technology Officer
51.60K
-2.62%
Mr. Edward (Ed) Stelmakh
Mr. Edward (Ed) Stelmakh
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
46.65K
-47.02%
Mr. Gregory D. (Greg) Wasson
Mr. Gregory D. (Greg) Wasson
Independent Director
Independent Director
43.90K
+29.00%
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 7月2日 周三
更新时间: 7月2日 周三
持股股东
股东类型
持股股东
持股股东
占比
Whetstone Capital Advisors, LLC
8.16%
Weintraub (Michael)
7.49%
BlackRock Institutional Trust Company, N.A.
6.31%
The Vanguard Group, Inc.
4.98%
Royce Investment Partners
4.27%
Other
68.79%
持股股东
持股股东
占比
Whetstone Capital Advisors, LLC
8.16%
Weintraub (Michael)
7.49%
BlackRock Institutional Trust Company, N.A.
6.31%
The Vanguard Group, Inc.
4.98%
Royce Investment Partners
4.27%
Other
68.79%
股东类型
持股股东
占比
Investment Advisor
27.45%
Investment Advisor/Hedge Fund
20.20%
Individual Investor
15.64%
Hedge Fund
9.85%
Research Firm
5.12%
Bank and Trust
0.09%
Insurance Company
0.04%
Pension Fund
0.03%
Other
21.57%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
260
14.87M
80.40%
-7.61M
2025Q1
267
15.34M
83.16%
-6.19M
2024Q4
295
14.49M
78.68%
-4.45M
2024Q3
303
15.96M
87.07%
-2.38M
2024Q2
340
16.48M
89.93%
-3.43M
2024Q1
347
15.94M
87.64%
-3.60M
2023Q4
378
15.63M
86.21%
-4.61M
2023Q3
399
14.49M
86.61%
-5.94M
2023Q2
406
14.23M
85.34%
-7.19M
2023Q1
407
14.85M
86.69%
-4.67M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Whetstone Capital Advisors, LLC
1.51M
8.16%
--
--
Apr 18, 2025
Weintraub (Michael)
1.38M
7.49%
--
--
Apr 29, 2025
BlackRock Institutional Trust Company, N.A.
1.17M
6.31%
+5.50K
+0.47%
Mar 31, 2025
The Vanguard Group, Inc.
921.85K
4.98%
-13.71K
-1.47%
Mar 31, 2025
Royce Investment Partners
994.30K
5.38%
-75.26K
-7.04%
Mar 31, 2025
William Blair & Company, L.L.C. (Research)
631.03K
3.41%
+29.65K
+4.93%
Mar 31, 2025
Rice Hall James & Associates, LLC
576.17K
3.12%
-1.57K
-0.27%
Mar 31, 2025
Febbo (William J)
530.85K
2.87%
-83.11K
-13.54%
Apr 29, 2025
Kennedy Capital Management LLC
478.40K
2.59%
-115.60K
-19.46%
Mar 31, 2025
Parkman Healthcare Partners LLC
475.00K
2.57%
+475.00K
--
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
Janus Henderson Small Cap Growth Alpha ETF
0.38%
iShares Micro-Cap ETF
0.05%
iShares Russell 2000 Growth ETF
0.02%
Avantis US Small Cap Equity ETF
0.02%
ProShares Hedge Replication ETF
0.01%
Proshares Ultra Russell 2000
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Global X Russell 2000 ETF
0.01%
iShares Russell 2000 ETF
0.01%
查看更多
Janus Henderson Small Cap Growth Alpha ETF
占比0.38%
iShares Micro-Cap ETF
占比0.05%
iShares Russell 2000 Growth ETF
占比0.02%
Avantis US Small Cap Equity ETF
占比0.02%
ProShares Hedge Replication ETF
占比0.01%
Proshares Ultra Russell 2000
占比0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
占比0.01%
ProShares UltraPro Russell2000
占比0.01%
Global X Russell 2000 ETF
占比0.01%
iShares Russell 2000 ETF
占比0.01%
分红派息
近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
tradingkey.logo
tradingkey.logo
日内数据由路孚特(Refinitiv)提供,并受使用条款约束。历史及当前收盘数据均由路孚特提供。所有报价均以当地交易所时间为准。美股报价的实时最后成交数据仅反映通过纳斯达克报告的交易。日内数据延迟至少15分钟或遵循交易所要求。
* 参考、分析和交易策略由第三方提供商Trading Central提供,观点基于分析师的独立评估和判断,未考虑投资者的投资目标和财务状况。
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有
KeyAI